We are 4-Fluorobenzoyl chloride CAS:403-43-0 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
CAS No: 403-43-0
Product Name: 4-Fluorobenzoyl chloride
para-fluorobenzoic acid chloride
p-Fluorobenzoic acid chloride
4-fluorobenzoic acid chloride
Density: 1.3±0.1 g/cm3
Boiling Point: 180.6±13.0 °C at 760 mmHg
Melting Point: 10-12 °C(lit.)
Molecular Formula: C7H4ClFO
Molecular Weight: 158.557
Flash Point: 82.2±0.0 °C
Exact Mass: 157.993469
Vapour Pressure: 0.9±0.3 mmHg at 25°C
Index of Refraction: 1.520
Storage condition: 2-8°C
Appearance: Colorless transparent liquid
Benzoyl chloride: ≤0.1%
Free acid: ≤0.3%
Intermediates of Flumorph CAS: 211867-47-9.
Be used as pesticide intermediate, mainly used in the synthesis of the fungicide Flumorph.
4-Fluorobenzoyl Chloride is used in the synthesis of tryphostins which act as inhibitors of EGF receptor and Erb82/neu tyrosine kinases. Also used in the synthesis of 1,2,4-triazole-3-thiones as antidepressant agents.
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Related News: Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.21901-29-1 On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.Ácido 2- (3-oxobutanoilamino) benzoico CAS:35354-86-0 The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.672-15-1 There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.